Biomendex

📍 Hervanta, Finland🗓 Founded 2018👥 16 employees💰 Last funded Sep 2019
Medical Equipment Manufacturing🌐 biomendex.com
Website LinkedIn
We at Biomendex develop and manufacture adaptable synthetic bone substitute materials for bone regeneration. Our invention, Adaptos®, is the first bioactive bone graft substitute that surgeons can cut, shape or squeeze into place. It is the only bone graft substitute that mimics bone by being resilient and bioactive. Our mission in Biomendex is to change the way bone voids are treated. We believe that delivering versatile and better working medical devices to operating theaters is an essential factor in improving surgical outcomes and minimizing the operational risks in bone regeneration. We believe in freedom to operate.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Finland
1
Frequently asked questions
Who invested in Biomendex?
Biomendex has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Biomendex last raise funding?
The most recent investment in Biomendex recorded on gritt.io was in September 2019.
When was Biomendex founded?
Biomendex was founded in 2018.
What industry is Biomendex in?
Biomendex operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Biomendex based?
Biomendex is headquartered in Hervanta, Finland.